A San-Félix - JoVE Visualize

Showing results (1-10 of 26) with videos related to

Pageof 3

Sort By:

Antiviral Chemistry & Chemotherapy|February 29, 2000

TSAO-T analogues bearing amino acids at position N-3 of thymine: synthesis and anti-human immunodeficiency virus activityC Chamorro, E De Clercq, J Balzarini, et al.

Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001

4"-H-TSAO-T, a novel prototype in the HIV-1 specific TSAO familyE Lobatón, S Velázquez, A San-Félix, et al.

Journal of Medicinal Chemistry|August 7, 1992

TSAO analogues. Stereospecific synthesis and anti-HIV-1 activity of 1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro -5''- (4''-amino-1'',2''-oxathiole 2'',2''-dioxide) pyrimidine and pyrimidine-modified nucleosidesM J Pérez-Pérez, A San-Félix, J Balzarini, et al.

Journal of Medicinal Chemistry|July 24, 1992

3'-Spiro nucleosides, a new class of specific human immunodeficiency virus type 1 inhibitors: synthesis and antiviral activity of [2'-5'-bis-O-(tert-butyldimethylsilyl)-beta-D-xylo- and -ribofuranose]-3'-spiro-5"-[4"-amino-1",2"-oxathiole 2",2"-dioxide] (TSAO) pyrimidine nucleosidesM J Camarasa, M J Pérez-Pérez, A San-Félix, et al.

Antiviral Chemistry & Chemotherapy|January 6, 1999

An approach towards the synthesis of potential metal-chelating TSAO-T derivatives as bidentate inhibitors of human immunodeficiency virus type 1 reverse transcriptaseC Chamorro, M J Camarasa, M J Pérez-Pérez, et al.

Journal of Medicinal Chemistry|October 29, 1993

TSAO analogues. 3. Synthesis and anti-HIV-1 activity of 2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl 3'-spiro-5''-(4''-amino-1'',2''-oxathiole 2'',2''-dioxide) purine and purine-modified nucleosidesS Velázquez, A San-Félix, M J Pérez-Pérez, et al.

Antimicrobial Agents and Chemotherapy|May 1, 1992

[2',5'-Bis-O-(tert-butyldimethylsilyl)]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide) (TSAO) derivatives of purine and pyrimidinenucleosides as potent and selective inhibitors of human immunodeficiency virus type 1J Balzarini, M J Pérez-Pérez, A San-Félix, et al.

Journal of Medicinal Chemistry|February 18, 1994

Novel series of TSAO-T derivatives. Synthesis and anti-HIV-1 activity of 4-, 5-, and 6-substituted pyrimidine analoguesA San-Félix, S Velázquez, M J Pérez-Pérez, et al.

Current Pharmaceutical Design|May 27, 2006

TSAO derivatives, inhibitors of HIV-1 reverse transcriptase dimerization: recent progressM J Camarasa, S Velázquez, A San-Félix, et al.

Journal of Medicinal Chemistry|May 12, 1995

Synthesis and anti-HIV activity of [AZT]-[TSAO-T] and [AZT]-[HEPT] dimers as potential multifunctional inhibitors of HIV-1 reverse transcriptaseS Velázquez, R Alvarez, A San-Félix, et al.

Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:

Pageof 3

Antiviral Chemistry & Chemotherapy|February 29, 2000

TSAO-T analogues bearing amino acids at position N-3 of thymine: synthesis and anti-human immunodeficiency virus activityC Chamorro, E De Clercq, J Balzarini, et al.

Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001

4"-H-TSAO-T, a novel prototype in the HIV-1 specific TSAO familyE Lobatón, S Velázquez, A San-Félix, et al.

Journal of Medicinal Chemistry|August 7, 1992

TSAO analogues. Stereospecific synthesis and anti-HIV-1 activity of 1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro -5''- (4''-amino-1'',2''-oxathiole 2'',2''-dioxide) pyrimidine and pyrimidine-modified nucleosidesM J Pérez-Pérez, A San-Félix, J Balzarini, et al.

Journal of Medicinal Chemistry|July 24, 1992

3'-Spiro nucleosides, a new class of specific human immunodeficiency virus type 1 inhibitors: synthesis and antiviral activity of [2'-5'-bis-O-(tert-butyldimethylsilyl)-beta-D-xylo- and -ribofuranose]-3'-spiro-5"-[4"-amino-1",2"-oxathiole 2",2"-dioxide] (TSAO) pyrimidine nucleosidesM J Camarasa, M J Pérez-Pérez, A San-Félix, et al.

Antiviral Chemistry & Chemotherapy|January 6, 1999

An approach towards the synthesis of potential metal-chelating TSAO-T derivatives as bidentate inhibitors of human immunodeficiency virus type 1 reverse transcriptaseC Chamorro, M J Camarasa, M J Pérez-Pérez, et al.

Journal of Medicinal Chemistry|October 29, 1993

TSAO analogues. 3. Synthesis and anti-HIV-1 activity of 2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl 3'-spiro-5''-(4''-amino-1'',2''-oxathiole 2'',2''-dioxide) purine and purine-modified nucleosidesS Velázquez, A San-Félix, M J Pérez-Pérez, et al.

Antimicrobial Agents and Chemotherapy|May 1, 1992

[2',5'-Bis-O-(tert-butyldimethylsilyl)]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide) (TSAO) derivatives of purine and pyrimidinenucleosides as potent and selective inhibitors of human immunodeficiency virus type 1J Balzarini, M J Pérez-Pérez, A San-Félix, et al.

Journal of Medicinal Chemistry|February 18, 1994

Novel series of TSAO-T derivatives. Synthesis and anti-HIV-1 activity of 4-, 5-, and 6-substituted pyrimidine analoguesA San-Félix, S Velázquez, M J Pérez-Pérez, et al.

Current Pharmaceutical Design|May 27, 2006

TSAO derivatives, inhibitors of HIV-1 reverse transcriptase dimerization: recent progressM J Camarasa, S Velázquez, A San-Félix, et al.

Journal of Medicinal Chemistry|May 12, 1995

Synthesis and anti-HIV activity of [AZT]-[TSAO-T] and [AZT]-[HEPT] dimers as potential multifunctional inhibitors of HIV-1 reverse transcriptaseS Velázquez, R Alvarez, A San-Félix, et al.

Pageof 3